Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
出版年份 2014 全文链接
标题
Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity
作者
关键词
-
出版物
Frontiers in Immunology
Volume 5, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2014-03-24
DOI
10.3389/fimmu.2014.00122
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cell-mediated Lysis of Myeloma
- (2015) Xiaosong Wu et al. NEOPLASIA
- Macrophage Migration Inhibitory Factor Contributes to the Immune Escape of Ovarian Cancer by Down-Regulating NKG2D
- (2014) M. Krockenberger et al. JOURNAL OF IMMUNOLOGY
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions
- (2013) J. Matta et al. BLOOD
- Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells
- (2013) N. Fiegler et al. BLOOD
- Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity
- (2013) K. S. Reiners et al. BLOOD
- VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide
- (2013) P Orlandi et al. BRITISH JOURNAL OF CANCER
- A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells
- (2013) Dhifaf Sarhan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulation of CD4+NKG2D+ Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15R and NKG2D Triggering
- (2013) A. I. Romero et al. CANCER RESEARCH
- Proapoptotic effects of the novel proteasome inhibitor b-AP15 on multiple myeloma cells and natural killer cells
- (2013) Xiaoli Feng et al. EXPERIMENTAL HEMATOLOGY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Conversion of Peripheral Blood NK Cells to a Decidual NK-like Phenotype by a Cocktail of Defined Factors
- (2013) A. S. Cerdeira et al. JOURNAL OF IMMUNOLOGY
- At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias
- (2013) Håkan Norell et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions
- (2013) Lisa M. Kopp et al. MOLECULAR IMMUNOLOGY
- Activating natural cytotoxicity receptors of natural killer cells in cancer and infection
- (2013) Joachim Koch et al. TRENDS IN IMMUNOLOGY
- Natural Killer Cells Modulation in Hematological Malignancies
- (2013) Céline Baier et al. Frontiers in Immunology
- Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells
- (2013) Kelly Hudspeth et al. Frontiers in Immunology
- Lung Tumor Microenvironment Induces Specific Gene Expression Signature in Intratumoral NK Cells
- (2013) Mélanie Gillard-Bocquet et al. Frontiers in Immunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
- (2013) James P Stevenson et al. OncoImmunology
- Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting
- (2013) David F Stroncek et al. Journal for ImmunoTherapy of Cancer
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
- (2012) N. Vey et al. BLOOD
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
- (2012) Esther M de Kruijf et al. BMC CANCER
- VEGF Receptor Inhibitors Block the Ability of Metronomically Dosed Cyclophosphamide to Activate Innate Immunity-Induced Tumor Regression
- (2012) J. C. Doloff et al. CANCER RESEARCH
- Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
- (2012) D. T. Le et al. CANCER RESEARCH
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
- (2012) Hidenari Nagai et al. Clinical & Developmental Immunology
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Latest advances and current challenges in the treatment of multiple myeloma
- (2012) Anuj Mahindra et al. Nature Reviews Clinical Oncology
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
- (2012) Andreas Lundqvist et al. Journal of Cancer
- Tumor microenvironment in NSCLC suppresses NK cells function
- (2012) Isabelle Cremer et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition
- (2011) E. Mamessier et al. CANCER RESEARCH
- B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors
- (2011) Tomonori Kaifu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
- (2011) Nicolas Penel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1
- (2011) M. J. Szczepanski et al. HAEMATOLOGICA
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence
- (2011) Hiroteru Kamimura et al. JOURNAL OF HEPATOLOGY
- Selenite Induces Posttranscriptional Blockade of HLA-E Expression and Sensitizes Tumor Cells to CD94/NKG2A-Positive NK Cells
- (2011) M. Enqvist et al. JOURNAL OF IMMUNOLOGY
- Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression
- (2011) Lucas E. Rossi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity
- (2011) Erica B. Wilson et al. PLoS One
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
- (2010) T. Nakahara et al. BLOOD
- Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse
- (2010) S Thiant et al. BONE MARROW TRANSPLANTATION
- Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers
- (2010) Lei Wu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lenalidomide down regulates the production of interferon-γ and the expression of inhibitory cytotoxic receptors of human Natural Killer cells
- (2010) Nicolas Dauguet et al. CELLULAR IMMUNOLOGY
- Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation
- (2010) Benjamin J. Schmiedel et al. INTERNATIONAL JOURNAL OF CANCER
- Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report
- (2010) Stacey L. Berg et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC
- (2010) Tim F. Greten et al. JOURNAL OF IMMUNOTHERAPY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Exposure of human leukemia NB4 cells to increasing concentrations of selenite switches the signaling from pro-survival to pro-apoptosis
- (2009) Liying Guan et al. ANNALS OF HEMATOLOGY
- Activin-A attenuates several human natural killer cell functions
- (2009) N. C. Robson et al. BLOOD
- Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells
- (2009) A. Lundqvist et al. BLOOD
- Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells
- (2009) M Lioznov et al. BONE MARROW TRANSPLANTATION
- Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
- (2009) Miroslaw J. Szczepanski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Selenite is a potent cytotoxic agent for human primary AML cells
- (2009) Eric Olm et al. CANCER LETTERS
- Natural Killer Cell IFN- Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients
- (2009) C. Menard et al. CANCER RESEARCH
- Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
- (2009) D. S. Schrump CLINICAL CANCER RESEARCH
- Clinical and Biological Efficacy of Recombinant Human Interleukin-21 in Patients with Stage IV Malignant Melanoma without Prior Treatment: A Phase IIa Trial
- (2009) I. D. Davis et al. CLINICAL CANCER RESEARCH
- Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
- (2009) A. Paschen et al. CLINICAL CANCER RESEARCH
- NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting
- (2009) R. W. McGilvray et al. CLINICAL CANCER RESEARCH
- Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity
- (2009) X. Wang et al. HAEMATOLOGICA
- Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9
- (2009) Keisuke Kohga et al. HEPATOLOGY
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Bortezomib-Treated Tumors Sensitized to NK Cell Apoptosis Paradoxically Acquire Resistance to Antigen-Specific T Cells
- (2009) A. Lundqvist et al. JOURNAL OF IMMUNOLOGY
- Proteasome Regulation of ULBP1 Transcription
- (2009) James E. Butler et al. JOURNAL OF IMMUNOLOGY
- The Kinase Inhibitors Sunitinib and Sorafenib Differentially Affect NK Cell Antitumor Reactivity In Vitro
- (2009) M. Krusch et al. JOURNAL OF IMMUNOLOGY
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- Demethylating treatment suppresses natural killer cell cytolytic activity
- (2009) Xiao-ning Gao et al. MOLECULAR IMMUNOLOGY
- Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
- (2009) Gal Markel et al. PLoS One
- The significance of Treg cells in defective tumor immunity
- (2008) Agata Kosmaczewska et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Induction of MHC class I-related chain B (MICB) by 5-aza-2′-deoxycytidine
- (2008) Kai-Fu Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen is Associated with Elevated IL-15 Levels
- (2008) Michael Boyiadzis et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
- (2008) M. M. Hipp et al. BLOOD
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT
- (2008) S Nguyen et al. BONE MARROW TRANSPLANTATION
- IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma
- (2008) Klaus Stensgaard Frederiksen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation
- (2008) Dan Zhu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Histone deacetylase inhibitors sensitize tumour cells for cytotoxic effects of natural killer cells
- (2008) Mareike Schmudde et al. CANCER LETTERS
- Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome Inhibitors
- (2008) M. Vales-Gomez et al. CANCER RESEARCH
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells
- (2008) L. Wu et al. CLINICAL CANCER RESEARCH
- Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
- (2007) G. Esendagli et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More